4.6 Article

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Urology & Nephrology

Active Surveillance: Very Much Preferred for Low-Risk Prostate Cancer

Matthew R. Cooperberg et al.

JOURNAL OF UROLOGY (2022)

Review Oncology

Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer

Francesca Lorenzin et al.

Summary: In addition to its role in development and in the vascular and hematopoietic systems, ERG plays a central role in prostate cancer. Inhibiting ERG activity may be a significant step in improving treatment efficacy for patients with ERG-positive prostate tumors.

CANCERS (2022)

Article Oncology

Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer

Carissa E. Chu et al.

Summary: Serial prostate magnetic resonance imaging in men with low-risk prostate cancer on active surveillance improves prognostic value and provides additional risk stratification. An increase in PI-RADS scores was associated with biopsy upgrade and definitive treatment. Validation in other cohorts is needed.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Oncology

PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer

E. Lopci et al.

Summary: In a highly-selected patient population, Ga-68-PSMA PET/CT demonstrates a higher diagnostic performance compared to PRI-MUS in the primary diagnosis of prostate cancer.

CLINICAL & TRANSLATIONAL ONCOLOGY (2021)

Article Urology & Nephrology

Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators

Ashkan Mortezavi et al.

Summary: New generation risk calculators (RCs) incorporating imaging can better discriminate clinically significant prostate cancer, but their predicted probabilities vary in accuracy. The Stockholm3 test achieves performance comparable with the best MRI RC without utilization of imaging.

EUROPEAN UROLOGY FOCUS (2021)

Article Urology & Nephrology

Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer

Claire M. de la Calle et al.

Summary: Screening algorithms with upfront liquid biomarker testing followed by multiparametric magnetic resonance imaging and biopsy at certain biomarker thresholds could reduce unnecessary biopsies, multiparametric magnetic resonance imaging, and the overdetection of Gleason grade 1 prostate cancer.

JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study

Giovanni Lughezzani et al.

Summary: This study aimed to evaluate the accuracy of microultrasound in diagnosing clinically significant prostate cancer, finding that microultrasound has high sensitivity but low specificity in the diagnosis of csPCa.

EUROPEAN UROLOGY FOCUS (2021)

Article Oncology

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

Elizabeth K. Bancroft et al.

Summary: The IMPACT study found that men carrying pathogenic variants in the MLH1, MSH2, and MSH6 genes had a significantly higher incidence of prostate cancer after the first round of PSA screening, supporting the use of targeted PSA screening in these men to identify clinically significant prostate cancer.

LANCET ONCOLOGY (2021)

Article Urology & Nephrology

Prospective Evaluation of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography in Primary Prostate Cancer Diagnosis

Egesta Lopci et al.

Summary: The study aimed to test the diagnostic performance of Ga-68-PSMA PET/CT in detecting clinically significant prostate cancer in patients with a high suspicion of cancer. Ga-68-PSMA PET/CT proved capable of accurately detecting prostate cancer and identifying clinically relevant PCa.

EUROPEAN UROLOGY FOCUS (2021)

Article Obstetrics & Gynecology

PCA3 AND TMPRSS:ERG ASSESSMENT IN SEMEN: RESULTS OF A PHASE I STUDY

Nahid Punjani et al.

FERTILITY AND STERILITY (2020)

Article Urology & Nephrology

The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer

Martina Maggi et al.

JOURNAL OF UROLOGY (2020)

Editorial Material Urology & Nephrology

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Matthew R. Cooperberg et al.

EUROPEAN UROLOGY (2019)

Review Biochemistry & Molecular Biology

Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis

Daniel F. Osses et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Urology & Nephrology

Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis

Herney Andres Garcia-Perdomo et al.

CENTRAL EUROPEAN JOURNAL OF UROLOGY (2018)

Article Public, Environmental & Occupational Health

TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences

Cindy Ke Zhou et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2017)

Review Oncology

Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review

Francesca Sanguedolce et al.

CLINICAL GENITOURINARY CANCER (2016)

Article Urology & Nephrology

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2

Jeffrey C. Weinreb et al.

EUROPEAN UROLOGY (2016)

Review Oncology

Clinical Utility of Biomarkers in Localized Prostate Cancer

Michael S. Leapman et al.

CURRENT ONCOLOGY REPORTS (2016)

Article Oncology

Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer

Simpa S. Salami et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)

Review Cell Biology

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

John R. Prensner et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Review Urology & Nephrology

Multiparametric magnetic resonance imaging in prostate cancer: present and future

John Kurhanewicz et al.

CURRENT OPINION IN UROLOGY (2008)

Article Pathology

TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion

Sven Perner et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Article Multidisciplinary Sciences

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer

SA Tomlins et al.

SCIENCE (2005)

Article Biochemistry & Molecular Biology

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

G Petrovics et al.

ONCOGENE (2005)